V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
Dodge & Cox Stock Fund Portfolio 13F
Dodge & Cox Stock Fund Holdings Activity
- Portfolio value:
- $91.17B≈ (+$2B≈)
- Previous value:
- $89.21B≈
- # of changes:
- 49
- New positions:
- 1
- Reported for:
- 30 Sep 2021 (Q3)
- Latest filing date:
- 26 Nov 2021
Dodge & Cox Stock Fund has disclosed a total of 49 changes to the portfolio in the (2021 Q3) SEC report(s): increased the number of shares of 42, bought 1 totally new and decreased the number of shares of 6 position(s).
What stocks did Dodge & Cox Stock Fund buy in 2021 Q3?
During 2021 Q3 Dodge & Cox Stock Fund has bought 43 securities out of which top 5 purchases (by % change to portfolio) were (WFC) Wells Fargo & Company (added shares +0.38%), (COF) Capital One Financial Corp (added shares +0.92%), (SCHW) Charles Schwab Corp (added shares +1.70%), (GOOG) Alphabet Inc, CL-C (added shares +0.92%) and (SNY) Sanofi ADR (added shares +39.67%).
What did Dodge & Cox Stock Fund invest in during 2021 Q3?
In the 2021 Q3 report(s) the following changes have been made to the top investments: (WFC) Wells Fargo & Company (added shares +0.38%), (COF) Capital One Financial Corp (added shares +0.92%), (SCHW) Charles Schwab Corp (added shares +1.70%), (GOOG) Alphabet Inc, CL-C (added shares +0.92%) and (SNY) Sanofi ADR (added shares +39.67%).
49 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Elanco Animal Health
|
new
|
+2,052,527
|
2,052,527
|
+0.07%
|
$31.89
|
-19.69%($25.61)
|
0.07%
|
2021 Q3
|
≈ 0.25 years
|
|
|
|
Sanofi ADR
|
+39.67%
|
+18,565,150
|
65,365,828
|
+0.98%
|
$48.21
|
-11.22%($42.80)
|
3.46%
|
2019 Q3
|
≈ 2.25 years
|
|
|
|
LyondellBasell Industries NV
|
+37.87%
|
+380,000
|
1,383,363
|
+0.04%
|
$93.85
|
-34.56%($61.42)
|
0.14%
|
2020 Q2
|
≈ 1.50 years
|
|
|
|
Gilead Sciences Inc
|
+29.16%
|
+5,675,600
|
25,138,812
|
+0.43%
|
$69.85
|
+85.34%($129.46)
|
1.93%
|
2019 Q3
|
≈ 2.25 years
|
|
|
|
Cigna Corp
|
+27.64%
|
+2,448,500
|
11,306,872
|
+0.54%
|
$200.16
|
+41.26%($282.74)
|
2.48%
|
2019 Q3
|
≈ 2.25 years
|
|
|
|
Novartis AG ADR
|
+25.76%
|
+4,099,244
|
20,013,900
|
+0.37%
|
$81.78
|
+87.83%($153.61)
|
1.80%
|
2019 Q3
|
≈ 2.25 years
|
|
|
|
VMware Inc
|
+18.10%
|
+798,100
|
5,207,000
|
+0.13%
|
$148.70
|
|
0.85%
|
2020 Q1
|
≈ 1.75 years
|
|
|
|
T-Mobile US Inc
|
+17.29%
|
+1,136,600
|
7,712,137
|
+0.16%
|
$127.76
|
+37.98%($176.28)
|
1.08%
|
2020 Q2
|
≈ 1.50 years
|
|
|
|
Incyte Corp
|
+16.29%
|
+1,377,100
|
9,830,300
|
+0.1%
|
$68.78
|
+72.83%($118.88)
|
0.74%
|
2019 Q3
|
≈ 2.25 years
|
|
|
|
Fiserv, Inc
|
+14.49%
|
+2,031,900
|
16,058,900
|
+0.24%
|
$108.50
|
-49.88%($54.38)
|
1.91%
|
2020 Q4
|
≈ 1.00 year
|
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.